Stability of erythropoietin repackaging in polypropylene syringes for clinical use

Introduction: Epoetin alfa (Eprex®) is a subcutaneous, injectable formulation of short half-life recombinant human erythropoietin (rHuEPO). To current knowledge there are no published studies regarding the stability of rHuEPO once repackaging occurs (r-EPO) for clinical trial purposes. Materials and...

Full description

Bibliographic Details

Published in:	Saudi Pharmaceutical Journal
Main Authors:	Angela Marsili, Giorgia Puorro, Chiara Pane, Anna de Rosa, Giovanni Defazio, Carlo Casali, Antonio Cittadini, Giuseppe de Michele, Brunello Ettore Florio, Alessandro Filla, Francesco Saccà
Format:	Article
Language:	English
Published:	Springer 2017-02-01
Subjects:	Erythropoietin Repackaging Polypropylene EPO Pharmacopeia
Online Access:	http://www.sciencedirect.com/science/article/pii/S1319016416000128